INSP vs. PEN, GMED, GKOS, TFX, HAE, MMSI, SOLV, IRTC, AXNX, and PRCT
Should you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Penumbra (PEN), Globus Medical (GMED), Glaukos (GKOS), Teleflex (TFX), Haemonetics (HAE), Merit Medical Systems (MMSI), Solventum (SOLV), iRhythm Technologies (IRTC), Axonics (AXNX), and PROCEPT BioRobotics (PRCT). These companies are all part of the "surgical & medical instruments" industry.
Inspire Medical Systems (NYSE:INSP) and Penumbra (NYSE:PEN) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, community ranking, profitability, media sentiment, earnings, risk and valuation.
In the previous week, Inspire Medical Systems had 2 more articles in the media than Penumbra. MarketBeat recorded 20 mentions for Inspire Medical Systems and 18 mentions for Penumbra. Inspire Medical Systems' average media sentiment score of 0.75 beat Penumbra's score of 0.28 indicating that Inspire Medical Systems is being referred to more favorably in the media.
Penumbra received 616 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. Likewise, 80.43% of users gave Penumbra an outperform vote while only 61.03% of users gave Inspire Medical Systems an outperform vote.
Inspire Medical Systems has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500.
Penumbra has higher revenue and earnings than Inspire Medical Systems. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.
94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by company insiders. Comparatively, 5.0% of Penumbra shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Penumbra has a net margin of 8.59% compared to Inspire Medical Systems' net margin of -3.39%. Penumbra's return on equity of 7.49% beat Inspire Medical Systems' return on equity.
Inspire Medical Systems presently has a consensus price target of $256.53, suggesting a potential upside of 57.76%. Penumbra has a consensus price target of $304.45, suggesting a potential upside of 49.09%. Given Inspire Medical Systems' higher probable upside, research analysts plainly believe Inspire Medical Systems is more favorable than Penumbra.
Summary
Penumbra beats Inspire Medical Systems on 11 of the 18 factors compared between the two stocks.
Get Inspire Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inspire Medical Systems Competitors List
Related Companies and Tools
